Martin Mangan, DO
Family Medicine · Rigby, IDNPI 1972709103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $118, 7.7 times the $15 reported in 2019. That places this record below the midpoint for family medicine clinicians in ID, where the typical reported total is $226.
Across 14 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$56
- Novo Nordisk$50
- Viatris Specialty LLC$21
- Jazz Pharmaceuticals Inc.$21
- AstraZeneca$19
- Astellas Pharma US Inc$19
- plus $57 from 4 others
What the payments were for
- Food & beverage$243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 3 | $56 |
| Novo Nordisk | 3 | $50 |
| Viatris Specialty LLC | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| GSK | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Harmony Biosciences LLC | 1 | $13 |
How this compares
$243 in reported general payments places this provider in the 50th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 14 | $351 |
| Cephalexin | 18 | $256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $192 |
| Quetiapine Fumarate | 15 | $133 |
| Prednisone | 27 | $71 |
| Metoprolol Succinate | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Rigby
- Richard HarperRigby$4K
- Kenneth CongerSandpoint$266K
- David ButukMeridian$206K
- Anne BroadwayIdaho Falls$184K
- Timothy McHughMeridian$165K
- Phyllis YouBoise$88K
- Ralph SutherlinSt Maries$73K
- Henry DownsCoeur D Alene$69K
- Crystal PyrakCoeur D Alene$46K
- Gary SoucieBlackfoot$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.